Serum chemokine levels as prognostic markers in patients with early systemic sclerosis: a multicenter, prospective, observational study

Minoru Hasegawa,Yoshihide Asano,Hirahito Endo,Manabu Fujimoto,Daisuke Goto,Hironobu Ihn,Katsumi Inoue,Osamu Ishikawa,Yasushi Kawaguchi,Masataka Kuwana,Fumihide Ogawa,Hiroki Takahashi,Sumiaki Tanaka,Shinichi Sato,Kazuhiko Takehara

Serum chemokine levels as prognostic markers in patients with early systemic sclerosis: a multicenter, prospective, observational study

2013

Minoru Hasegawa
Yoshihide Asano
Hirahito Endo
Manabu Fujimoto
Daisuke Goto
Hironobu Ihn
Katsumi Inoue
Osamu Ishikawa
Yasushi Kawaguchi
Masataka Kuwana
Fumihide Ogawa
Hiroki Takahashi
Sumiaki Tanaka
Shinichi Sato
Kazuhiko Takehara

Objective To assess the utility of serum chemokine levels as a prognostic indicator of disease progression in systemic sclerosis (SSc) patients with early onset disease.

Keywords:

Diabetes mellitus
Chemokine
Observational study
Disease
Interleukin 8
Pathology
Medicine
disease progression
Immunology
in patient
early onset disease
Rheumatology
Physical therapy
Internal medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations